AMICUS THERAPEUTICS, INC. — Director's Dealing 2022

Jan 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2021-12-31

Reporting Person: Clark David Michael (Chief People Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-31	Common Stock	F	7280	$11.55	Disposed	161599	Direct
2022-01-02	Common Stock	F	10665	$11.55	Disposed	150934	Direct
2022-01-04	Common Stock	F	2692	$12.48	Disposed	148242	Direct